Ilich A, Gernsheimer TB, Triulzi DJ, et al. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia. Blood Adv. 2023;7(6):900-908.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362531/
https://www.ncbi.nlm.nih.gov/pubmed/37390313
http://dx.doi.org/10.1182/bloodadvances.2023010270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362531/
https://www.ncbi.nlm.nih.gov/pubmed/37390313
http://dx.doi.org/10.1182/bloodadvances.2023010270

Ejemplares similares